Related Experiment Video
Updated: May 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Significant publications on infectious diseases pharmacotherapy in 2012
Dana R Bowers1, Andrew S Hunter, David M Jacobs
1Dana R. Bowers, Pharm.D., BCPS, is Infectious Diseases Pharmacotherapy Fellow, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX. Andrew S. Hunter, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Houston. David M. Jacobs, Pharm.D., BCPS, is Postgraduate Year 2 Infectious Diseases Resident, Cardinal Health, Houston, and Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston. Kristi M. Kuper, Pharm.D., BCPS, GSPC, is Clinical Pharmacy Manager, VHA Performance Services, Houston. William L. Musick, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases; and Katherine K. Perez, Pharm.D., BCPS, is Clinical Specialist-Infectious Diseases, The Methodist Hospital, Houston. Dhara N. Shah, Pharm.D., BCPS, is Research Assistant Professor, Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston. Amy N. Schilling, Pharm.D., BCPS, is Clinical Practice Specialist-Internal Medicine/Infectious Diseases, University of Texas Medical Branch, Galveston.
Purpose:
The most important articles pertaining to infectious diseases (ID) pharmacotherapy published in 2012, as nominated and ranked by panels of pharmacists and physicians with ID expertise, are summarized.
Summary:
Members of the Houston Infectious Diseases Network were asked to nominate articles on ID research published in prominent peer-reviewed journals during the period January 1-December 31, 2012, with a major impact in the field of ID pharmacotherapy. A list of 42 nominated articles on general ID-related topics and 8 articles pertaining to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) was compiled. In a survey conducted in January 2013, members of the Society of Infectious Diseases Pharmacists (SIDP) were asked to select from the list 10 general ID articles and 1 HIV/AIDS-related article that they considered to be the most important. Of the 180 SIDP members surveyed, 100 (55%) and 44 (24%) participated in ranking the general ID and HIV/AIDS-related articles, respectively. Summaries of the highest-ranked articles in both categories are presented here.
Conclusion:
With the volume of published ID-related research growing each year, both ID specialists and nonspecialists are challenged to stay current with the literature. Key ID-related publications in 2012 included updated recommendations on management of diabetic foot infections, articles on promising approaches to prevention and early treatment of HIV disease, and reports on developments in research on pharmacotherapies for methicillin-resistant Staphylococcus aureus bacteremia and Klebsiella pneumoniae infections.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:29Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Microorganisms in Medicine and Therapeutics
Inhibitors of Viral Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...